Bipolar disorder drugs market seen reaching $10.83 billion by 2030

Nov. 20, 2026
Bipolar disorder drugs market seen reaching $10.83 billion by 2030
By AI, Created 14:30 UTC, Nov 20, 2026, AGP -

The bipolar disorder drugs and treatment market is projected to grow from $8.16 billion in 2025 to $10.83 billion by 2030, according to The Business Research Company. The report points to rising mental health diagnoses, broader treatment access and new drug delivery approaches as key drivers.

Why it matters: - Bipolar disorder affects mood stability, daily functioning and long-term quality of life, so growth in treatment access can directly affect patient outcomes. - The market’s steady 5.8% annual growth rate signals continued demand for psychiatric care, medications and outpatient services.

What happened: - The Business Research Company released its Bipolar Disorder Drugs and Treatment Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The market was estimated at $8.16 billion in 2025 and is projected to reach $8.63 billion in 2026. - The forecast puts the market at $10.83 billion by 2030, at a 5.8% CAGR. - The report was published in London on Nov. 20, 2026. - A free sample report is available.

The details: - The market’s recent growth has been driven by higher mental health awareness, broader antidepressant use, improved psychiatric hospital infrastructure, availability of mood stabilizers and rising diagnosis rates. - Future growth is expected to come from precision psychiatry, long-acting injectable medications, digital mental health tools, personalized treatment strategies and expansion of outpatient psychiatric services. - Expected product and care trends include more combination drug therapies, stronger focus on long-term mood stabilization, wider use of atypical antipsychotics, relapse prevention programs and better treatment adherence efforts. - Bipolar disorder drugs and treatment are aimed at reducing severe mood swings and supporting sustained mental stability. - The treatment approach also addresses sleep disturbances, anxiety and concentration problems. - The report says rising global mental health disorders are a major growth driver. - Chronic stress from work demands, financial concerns and social expectations is adding to the burden of mental illness. - The National Alliance on Mental Illness reported in 2024 that mood and psychosis-related disorders lead to nearly 600,000 hospitalizations a year among Americans ages 18 to 44. - A full market report is available.

Between the lines: - The forecast points to a market that is growing steadily rather than spiking, which suggests treatment demand is broadening across both drugs and care delivery. - The emphasis on long-acting injectables, digital tools and outpatient services suggests the market is moving beyond hospital-centered care toward more continuous management. - North America held the largest market share in 2025, while Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The regional outlook reflects stronger healthcare infrastructure in North America and expanding access, diagnosis and investment in Asia-Pacific. - The analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

What's next: - The market is expected to keep expanding through 2030 if diagnosis rates, access to care and treatment innovation continue to improve. - The report highlights strategic tools added to the 2026 edition, including market attractiveness scoring, TAM analysis, company scoring matrices, Excel dashboards, market hotspot infographics and future trend analysis. - The Business Research Company expects updated graphics and tables to support broader market planning and competitive tracking.

The bottom line: - Bipolar disorder treatment remains a steady-growth mental health market, with demand supported by rising diagnoses, expanding care access and new therapy models.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Asia News Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Asia News Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.